[Effects of nimodipine on mental deterioration in subjects with chronic cerebrovascular pathology].

In order to assess the efficacy of Nimodipine against a polymorphous pathology, such as chronic cerebrovascular insufficiency, the authors studied 96 subjects affected by chronic cerebrovascular diseases aged between 65 and 85 years old. The various symptoms were evaluated individually using tests and subjects were then divided into two groups on the basis of overall results. All subjects were followed for six months and then reassessed using the above-mentioned tests at the end of the study. From results obtained, it appears that Nimodipine is a useful tool for controlling the most common symptoms associated with mental deterioration in subjects affected by chronic cerebrovascular disorders.